Quick Answer
Calidi Biotherapeutics, Inc. reported Cash and Equivalents of $1.06 million for fiscal year 2021.
Calidi Biotherapeutics, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2021 | $1.06M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2021 | $1.20M | — | — |
| March 31, 2021 | $0.00 | — | — |
- The most recent figure is from Calidi Biotherapeutics, Inc.’s fiscal year 2021 report (Form 10-K), filed with the SEC on March 31, 2022.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: